Revvity Signals Unveils Signals ClinicalTM – Accelerating Clinical Decision Making & Data Analytics

2024-02-14 05:28:52

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a-service (SaaS), an end-to-end clinical data science platform designed to centralize all clinical trial data, provide rapid and actionable insights for faster clinical decision-making and delivery Accelerated in the market of medicines. This state-of-the-art solution, when combined with enterprise-class Spotfire visual analytics, has the potential to redefine how the pharmaceutical, biotechnology and contract research industries approach clinical trial data, offering an unprecedented level of access and insights to drive forward clinical development and therapeutic innovations.

Kevin Willow, VP and General Manager of Revvity Signals Software, Inc., highlighted the transformative potential of Signals Clinical, stating, “In the high-stakes fields of pharma, biotech and contract research, the ability to quickly and safely bring new treatments to market is paramount. Signals Clinical is our answer to the industry’s urgent need for a solution that is not only designed to protect patient safety but also empowers data-driven decision making with near-real-time analytics. By combining this platform with advanced data and visualization tools, we enable our customers to navigate the complexity of clinical development more easily and efficiently, thereby speeding up the delivery of new drugs to patients.”

Concentration of clinical data for accelerated decision making

Signals Clinical centralizes all clinical development data in one place and enables self-service access to clinical trial data, providing users with a complete picture of patient safety, treatment efficacy and trial progress. This centralization enables quick and actionable insights, enables faster and more informed clinical decision-making, and significantly accelerates the time to market for essential treatments.

Empowering life sciences with advanced analytics

Signals Clinical, combined with Spotfire not only streamlines the data preparation process, but also improves the delivery of strategic analyses, such as safety, efficacy and cross-study analysis. By reducing the time and resources spent on manual data processing, Signals Clinical enables organizations to focus on delivering critical clinical trial insights and fostering cross-functional collaboration.

Leading with FAIR methods for collaborative data management

The platform advocates FAIR principles, optimizes data preparation, reduces effort and maximizes value. It offers customizable workflows for data management, clinical review and research monitoring, along with integrated collaboration tools. These features allow queries to be recorded and addressed by study administrators, improving collaboration and increasing overall team efficiency for clinical researchers.

Revvity Signals Software will debut its Clinical Signals platform at the 15th annual SCOPE conference (booth #236), February 11-14, in Orlando, Florida.